# Cerebellar rTMS for the Treatment of Schizophrenic Patients

> **NCT01072617** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** Transcranial magnetic stimulation via MagPro x100 device

## Key facts

- **NCT ID:** NCT01072617
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072617, "Cerebellar rTMS for the Treatment of Schizophrenic Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01072617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*